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Abstract
Background: NURR1 (also named as NR4A2) is a member of the steroid/thyroid hormone receptor family, which
can bind to DNA and modulate expression of target genes. Previous studies have shown that NURR1 is essential
for the nigral dopaminergic neuron phenotype and function maintenance, and the defects of the gene are
possibly associated with Parkinson’s disease (PD).
Results: In this study, we used new born Nurr1 knock-out mice combined with Affymetrix genechip technology
and real time polymerase chain reaction (PCR) to identify Nurr1 regulated genes, which led to the discovery of
several transcripts differentially expressed in the nigro-striatal pathway of Nurr1 knock-out mice. We found that an
axon genesis gene called Topoisomerase IIb (Top IIb) was down-regulated in Nurr1 knock-out mice and we
identified two functional NURR1 binding sites in the proximal Top IIb promoter. While in Top IIb null mice, we saw
a significant loss of dopaminergic neurons in the substantial nigra and lack of neurites along the nigro-striatal
pathway. Using specific TOP II antagonist ICRF-193 or Top IIb siRNA in the primary cultures of ventral
mesencephalic (VM) neurons, we documented that suppression of TOP IIb expression resulted in VM neurites
shortening and growth cones collapsing. Furthermore, microinjection of ICRF-193 into the mouse medial forebrain
bundle (MFB) led to the loss of nigro-striatal projection.
Conclusion: Taken together, our findings suggest that Top IIb might be a down-stream target of Nurr1, which
might influence the processes of axon genesis in dopaminergic neurons via the regulation of TOP IIb expression.
The Nurr1-Top IIb interaction may shed light on the pathologic role of Nurr1 defect in the nigro-striatal pathway
deficiency associated with PD.
Background
Mesencephalic dopaminergic neurons (MDNs) arise from
a common set of precursors, but mature to direct a wide
range of brain functions [1]. The common feature of these
cells is their ability to regulate dopamine (DA) synthesis,
transmission and uptake. One of the most important func-
tions MDNs possess is the control over voluntary move-
ments. Also, their degeneration in substantial nigra (SN) is
ah a l l m a r ko fP a r k i n s o n ’s disease (PD) [2]. It becomes a
high priority to understand the molecular mechanism and
pathway by which MDNs develop and maintain their func-
tions [3,4]. NURR1, a transcription factor belonging to the
orphan nuclear receptor superfamily, recognizes DNA by
binding hormone-response elements in the promoters of
regulated target genes [5]. It regulates the expression of
tyrosine hydroxylase (TH), dopamine transporter (DAT),
vesicular monoamine transporter 2 (VMAT2), and L-aro-
matic amino acid decarboxylase (AADC), all of which are
important in the synthesis and storage of DA [6-9]. Nurr1
deficiency results in impaired dopaminergic function and
increased vulnerability of MDNs to the oxidative insults
[10,11]. Decreased NURR1 expression is found in the
autopsied PD midbrains, particularly in neurons contain-
ing Lewy bodies, as well as in peripheral lymphocytes of
patients with parkinsonian disorders [12]. Also, several
studies have found that variations in Nurr1 gene might be
risk factors for PD [13]. All these studies suggest that
NURR1 is essential in the development and differentiation
of MDNs phenotype, function maintenance and neuropro-
tection, and has a distinct role in the pathology of PD
[10,14].
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influence the development and differentiation of MDNs
through the regulation of axon genesis. In Nurr1 null
mice, Wallen and his colleagues, using Fluorogold as a
retrograde axonal tracer, did not observe innervations of
the striatum by MDN precursors [15]. In primary ventral
mesencephalon (VM) cultures, VM cells from wide type
(WT) mice showed clear bundles of dopaminergic fibers
while VM cells from Nurr1 deficient mice displayed a dif-
fuse network of processes without the formation of bun-
dles of dopaminergic fibers after 7 days in culture [16].
An in vitro study also showed that NURR1 induced mor-
phological differentiation in MN9D cells characterized by
long, usually bipolar neurites, while mock-transfected
cells retained the usual round shape, bearing occasionally
very short neurites [17]. It is very interesting to know
that gene neuropilin, a receptor protein involved in axon
guidance and angiogenesis, has been reported as one of
Nurr1 downstream targets [1,18]. Recently, Jacobs et al.
performed a study that combined gene expression micro-
arrays and chromatin immunoprecipitation (ChIP)-on-
chip analysis on E14.5 Nurr1
-/- and Nurr1
+/+ embryos
and thereby identified Dlk1, Ptpru and Klhl1 as novel
Nurr1 target genes in vivo [19]. Klhl1 is the homolog of
the ACTIN-organizing kelch gene in drosophila and is
described as playing a central role in neurite outgrowth
[20,21]. PTPRs have also been involved in axonal growth
and guidance [22]. These data raise the possibility that
NURR1 may play an important role either directly or
indirectly in the fasciculation of dopaminergic axons.
In our efforts to understand the mechanism by which
NURR1 regulates dopaminergic cell development and
differentiation, we used Nurr1 knock-out mice, in combi-
nation with microarray technology, to identify novel
Nurr1 target genes. Using high stringent filtering criteria,
several genes were identified as being regulated by Nurr1.
Of these genes, we are particularly interested in the gene
Topoisomerase IIb (Top IIb). Eukaryotic TOP II is present
in two isoforms: a and b.T h ea isoform expresses in
proliferating cells and is mainly required for chromosome
segregation. The b isoform is enriched in post-mitotic
neuronal cells in developing brains [23]. This nuclear
enzyme is the catalytic entity operating directly on chro-
matin DNA and controls and alters the topologic states
of DNA during transcription. Previous studies show that
TOP IIb plays a remarkable role in neurodevelopment
and axon outgrowth [24-26]. Top IIb knock-out mice
exhibit a specific and predominant defect in neuronal
development. The defects in motor axon growth in Top
IIb mutant mice cause breathing problems and death of
the pups shortly after birth [24]. Nurr1 knock-out mice
also die soon after birth due to respiratory failure [27].
Studies using brain-specific Top IIb knock-out mice have
demonstrated an aberrant lamination pattern in the
developing cerebral cortex and a similar prenatal death
phenotype suggesting an essential role of TOP IIb in
brain development [28]. In the cerebral cortex of Top IIb
null mice, neurons born at later stages of corticogenesis
fail to migrate to the superficial layers, motor axons fail
to contact skeletal muscles, and sensory axons fail to
enter the spinal cord. Isolated cortical neurons from Top
IIb knock-out embryos exhibit shorter neurites than
those from their wild type counterparts, confirming the
role of TOP IIb in neurite outgrowth [26]. TOP II inhibi-
tor ICRF-193 significantly blocks neurite outgrowth and
growth cone formation in cultured cerebella granule neu-
rons, dorsal root ganglions and cortical neurons [26].
The present study aims to test the hypothesis that Top
IIb is a downstream target of Nurr1 and NURR1 might
influence the processes of axon genesis via the regula-
tion of TOP IIb expression.
Results
Agenesis of dopaminergic neuron axons in Nurr1 knock-
out mice and in Nurr1 deficient SH-SY5Y cell line
Sagittal sections of postnatal brains of WT, Nurr1
+/- and
Nurr1
-/- mice were stained with TH antibody. In WT
m o u s eb r a i n s ,ab i gb u n c ho fT H
+ axons extended ros-
trally along the medial forebrain bundle (MFB), and then
spread to the entire striatal complex. In Nurr1
+/- mice,
we only observed sparse TH
+ axons processed along the
nigro-striatal pathway. The density of the TH
+ nerve
terminals in the striatum also declined significantly. In
parallel with the total loss of TH
+ neurons in SN of
Nurr1
-/- mice, little TH
+ axons were observed in the
pathway (data not shown).
To verify the in vivo result and study the role of NURR1
on the neurites that have already been extended, stable
SH-SY5Y cell lines were screened out after transfection
with Nurr1 siRNA plasmids or scrambled siRNA plasmids.
The SH-SY5Y cell line is a human derived neuroblastoma
cell line. The cells both propagate via mitosis and differ-
entiate by extending neurites to the surrounding area.
Clones with decreased expression of NURR1 were identi-
fied by Western blot analysis. As shown in Figure 1, Nurr1
siRNA plasmids inhibited neurite outgrowth of SH-SY5Y
cells significantly (about 80% reduction of the neurite
length). The in vitro data indicate that NURR1 is necessary
for the maintenance of extended neurites.
Top IIb is identified as a target of Nurr1
M i c r o a r r a ys t u d yi ne a r l ye m b r y o n i cs t a g eo fNurr1
-/-
mice has been reported [19]. The purpose of this study
was to determine the expression profiles at the late devel-
opment stage after Nurr1 gene was knocked out. Accord-
ing to the study by Wallen et al., even in the absence of
Nurr1, neuronal differentiation was induced and expres-
sion of several genes, including homeobox transcription
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genase 2, could be detected in developing dopaminergic
cells [15]. It means the dopaminergic progenitor cells
may still exist in this area. We propose that the loss of
TH
+ neurons in VM area of Nurr1
-/- mice may be due to
the defect of the terminal differentiation of these pro-
genitor cells. Based on our previous work at our lab
using zebra fish model, we found that the dopaminergic
neurons still exists in the posterior tuberculum of the
zebra fish after we knocked down NURR1 expression
level using morpholino technique, suggesting that
NURR1 may play an important role in the differentiation
and maturation rather than the survival of dopaminergic
progenitors in the posterior tuberculum area during zeb-
rafish embryogenesis [29]. Therefore, it is of importance
to study the gene expression changes of these non-term-
inal differentiated dopaminergic progenitor cells. Microar-
ray analysis was employed and several genes were
identified with altered expression in the mesencephalon of
WT and Nurr1
-/- mice at P1 (Additional file 1, Table S1).
Some of these genes have been previously reported to be
regulated by Nurr1, including Dat and Aldh1a1, giving
confidence that the microarray results represented real
changes in expression in vivo. We also found that some
known Nurr1 targeted genes were not in this list. This
could be due to our high stringent filtering criteria. For
example, TH,ak n o w nNurr1 regulated gene, is down
regulated 1.85 fold in Nurr1
-/- mice, thus missing the
stringent criteria for inclusion. Among the potential tar-
gets of Nurr1, Top IIb was highly focused on for its role in
axon genesis [24-26]. Quantitative real-time polymerase
chain reaction (PCR) analysis of Top IIb also showed a
1.75 fold down regulation in Nurr1
-/- mice compared
with WT ones.
To verify the in vivo results, we examined the effect of
decreasing or over-expressing NURR1 level on TOP IIb
expression in a cell line that expresses both of the genes
under normal growth conditions. The cells chosen were
Figure 1 Axon genesis deficiency in Nurr1 deficient SH-SY5Y cell line. A. SH-SY5Y cells were respectively transfected with pSUPER-random
and pSUPER-Nurr1 siRNA plasmids. After selection by neomycin, stably transfected cell lines with GFP fluorescence were picked on an inverted
fluorescence microscope. B. The clones with decreased NURR1 expression level were identified by Western blot analysis. TOP IIb protein level
was also analyzed in Nurr1 deficient cell line. C. The average neurite length (total neurite length/cell number) was determined from more than
100 cells. Bars represent the mean ± SEM (n = 3 independent experiments). Neurite outgrowth in the pSUPER-random and pSUPER-Nurr1 siRNA
plasmids transfected cell lines showed significant difference. **P <0.01 vs. random control.
Heng et al. Molecular Neurodegeneration 2012, 7:4
http://www.molecularneurodegeneration.com/content/7/1/4
Page 3 of 18Neuro-2a (N2a) cells, a murine albino neuroblastoma,
which constitutes a model system for neurons and starts
to be used as an expression system [30]. NURR1 expres-
sion was blocked using three sequences of stealth siRNA
targeting different sites of mouse Nurr1 gene. As shown
in Figure 2A-C, application of the three different target
sequences significantly suppressed the NURR1 mRNA
and protein expression levels, and consequently
decreased the TOP IIb expression levels. When we tran-
siently over-expressed NURR1 in N2a cells, both the
mRNA and protein expression levels of TOP IIb were
also elevated (Figure 2D-F). In this study, scrambled
siRNA was used as a negative control and LAMIN B was
used as an internal control for the nucleoprotein. These
data indicate that NURR1 could regulate the expression
of TOP IIb and NURR1 is necessary for the maintenance
of TOP IIb expression in cell cultures.
The upstream promoter region of the Top IIb gene can
be transactivated by NURR1 and contains multiple NGFI-B
response element (NBRE)-like sequence motifs
NURR1 was originally characterized by binding as a
monomer to a sequence motif named NBRE: 5’-
AAAGGTCA-3’ [31,32]. To determine whether NURR1
transactivates the Top IIb promoter activity via interacting
with binding motif(s), we searched the 5’ flanking
sequences for the potential NURR1-binding sequence
motifs. Remarkably, 11 NBRE-like motifs (no more than
one base deviation from the consensus NBRE) were identi-
fied within the 10 kb upstream region (Table 1). Among
these, two reside within 800 bp proximal region: one at
-174 to -167 bp and the other at -720 to -713 bp. A 1600
bp fragment of the mouse genomic sequence upstream of
the Top IIb transcription start site (Top IIb+237-1480)
containing the two potential NBREs was isolated and
cloned into a luciferase reporter plasmid pGL3-Basic.
In transient transfection, the effect plasmid pCI-Nurr1
was co-transfected with the reporter plasmid pGL3-Top
IIbpro into SH-SY5Y cells. Different amounts of the effec-
ter plasmid were used in co-transfection assay. To com-
pare the fold transactivation by NURR1, the luciferase
activity in the presence of empty vector (pCI) was set to 1.
Cells were harvested 48 hours after transfection. As shown
in Figure 3A, NURR1 can transactivate the Top IIb pro-
moter activity in a dose-dependent manner in SH-SY5Y
cells.
Furthermore, SH-SY5Y cells were transiently transfected
with expression vector encoding NURR1
R334A,aD N A
binding deficient mutant, and pGL3-Top IIbpro. As shown
in Figure 3B, NURR1
R334A was incapable of inducing Top
IIb expression. This result indicates that the natural struc-
ture of NURR1 is necessary to transactivate the expression
of Top IIb.
To investigate whether the two putative NBREs are
important for NURR1 dependent activation of the Top IIb
promoter, point mutations that disrupt these sequences
were introduced into the Top IIb promoter constructs by
site-directed mutagenesis. SH-SY5Y cells were transiently
transfected with constructs harboring mutations either in
NBRE1 or NBRE2. Both of the mutations clearly reduced
the ability of NURR1 to activate the promoter (Figure 3C).
This result strongly supports the idea that NURR1 directly
activates Top IIb transcription by interacting with some or
both of these cis-elements. Comparing the two sites,
mutation of the NBRE2 site reduced the luciferase activity
more robustly. One possible reason may be that NBRE2 is
closer to the transcription start site and more sensitive to
the activation of NURR1.
Consistent with above results, we generated mutant
reporter constructs in which the NBRE1 or NBRE2 site
was changed to a consensus NBRE motif (F: AAAGGTCA;
R: TGACCTTT). When co-transfected with NURR1
expression plasmid to SH-SY5Y cells, transcription activ-
ities of the reporter gene were stimulated more in the
mutant constructs than in the original ones. Luciferase
activities increased 1.23 fold in NBRE(C)1 construct and
1.7 fold in NBRE(C)2 construct (Figure 3D).
A possible explanation for the relatively weak activation
by NURR1 over-expression could be that the promoter is
already activated due to basal expression of NURR1 in
these cells. Indeed, a dominant negative derivative of
NURR1 (dnNURR1) that lacks a functional activation
domain, repressed the basal activity of the Top IIb promo-
ter indicating that it competes with endogenous NURR1
in the cells (Figure 3E).
NURR1 binds directly to the endogenous Top IIb
promoter
The above results suggest that NURR1 has the potential to
regulate the Top IIb promoter and the identified NBREs
contribute to the activation. We used ChIP assay to verify
that NURR1 was recruited to these sites at the endogenous
promoter. Proteins were cross-linked to chromatin and
immunoprecipitated with an antibody against NURR1.
PCR primers corresponding to either NBRE1 and NBRE2
or a control sequence located 3700 bp downstream of the
transcriptional start site were used in these experiments.
As shown in Figure 3F, NURR1 was recruited to the
NBRE2 in the Top IIb promoter, but neither to NBRE1
nor to the control region.
NURR1 and TOP IIb co-express in the VM of mouse
Next we determined if NURR1 and TOP IIb co-express
in vivo in the mouse brain. Expression patterns of
NURR1 and TOP IIb were analyzed by double immuno-
fluorescence staining (Figure 4). Data showed that
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Page 4 of 18Figure 2 NURR1 is necessary for the maintenance of TOP IIb expression in cell cultures. A. Knock-down NURR1 expression level in N2a
cells by stealth siRNA down-regulates TOP IIb protein level. Nucleoprotein of the cells was extracted 3 days after transfection. B. Statistic analysis
of the protein levels. Data obtained for NURR1 and TOP IIb expression levels were normalized to LAMIN B expression level. C. Knock-down
NURR1 expression level in N2a cells by stealth siRNA down-regulates Top IIb mRNA expression. Total RNA of the cells was extracted 48 hours
after transfection. We further validated the expression of Nurr1 and Top IIb mRNA by real-time PCR analysis. Data obtained for Nurr1 and Top IIb
expression levels were normalized to Gapdh expression level. D. Over-expression NURR1 in N2a cells increases TOP IIb protein level. E. Statistic
analysis of the protein levels. F. Over-expression NURR1 in N2a cells increases Top IIb mRNA expression level. Expression levels expressed relative
to a negative control (random sequence). Each bar represents the average of three individual wells, and samples were triplicate. Error bars
indicated the standard error for each group. **P <0.01 vs. negative control.
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neurons as well as in cells of the hippocampus and cere-
brum cortex (Data not shown). TOP IIb expression seen
in the Nurr1
-/- mice was dramatically weakened and lim-
ited to the medial part of this area at P1. Together these
findings suggest that NURR1 is essential for high expres-
sion of TOP IIb in the VM area where they co-express.
TOP IIb expresses in VM dopaminergic neurons
In order to study the function of TOP IIb in VM dopami-
nergic neurons, we designed an experiment to verify
whether TOP IIb expresses in these neurons. Double
immunostaining of TH and TOP IIb was performed in
serial coronal sections of the mesencephalons from P1
WT mice. As shown in Figure 5, TOP IIb localized in the
nucleus of TH
+ neurons both in SN pars compacta (SNc)
and ventral tegmental area (VTA). It indicates that TOP
IIb might be involved in the development of VM dopami-
nergic neurons.
TOP IIb inhibition affects neurite outgrowth and function
maintenance of dopaminergic neurons
The catalytic inhibitor of TOP II, ICRF-193, is known to
down-regulate TOP II by activating a 26s proteome path-
way [33]. The drug binds specifically to the enzyme and
stabilizes the TOP II-DNA covalent complex by prevent-
ing the ligation of the transiently cleaved DNA strands
[34]. VM neurons isolated from 13.5-day-old mouse pups
were cultured on PDL-coated cover slips. After 2 hours,
ICRF-193 was added to a final concentration of 20 μMo r
40 μM and the incubation was continued for another 5
days. Neurons were fixed and stained with anti-MAP2 or
anti-TH antibodies. Through determination of the MAP2
+
and TH
+ neuron loss by cell counting, we found no differ-
ence regarding the total neuron number or dopaminergic
neuron number between the ICRF-193 and the vehicle
treatment groups. However, phenotype-defined dopami-
nergic neurons exhibited more shortened neurites after
ICRF-193 treatment (Figure 6A-D). To confirm the results
obtained by the use of ICRF-193, we tranfected the ventral
MDNs with Top IIb siRNA plasmids or random sequence
control plasmids before seeding using AMAXA nucleofec-
tor instrument. Five days after transfection, cells were
fixed and stained with anti-TH and anti-GFP antibodies.
As showing in Figure 6G and 6H, the dopaminergic neu-
rons transfected with Top IIb siRNA plasmids could not
extent their neurites normally, bearing shortened neurites
compared with the cells transfected with the random
sequence plasmids. These data suggest that the deficiency
of Top IIb does not cause the neuron injury in primary
VM cultures, but only affects the neurite extension. Dopa-
minergic neurons seem more vulnerable than general neu-
rons to ICRF-193 exposure.
The central component in the road trip of axon genesis
is the growth cone, a dynamic structure that is located at
the tip of the growing axon. The highly dynamic behavior
of the growth cone and its responsiveness to multiple
sources of spatial information allows it to find its target
with an impressive level of accuracy. The receptors on the
surface of the growth cone can sense the guidance cues in
the extracellular matrix and the surrounding cell surface
and transfer the attractive or repulsive signals into the cell
that then guide the neurite to its destination. ICRF-193
treatment affected the growth cone formation in primarily
cultured dopaminergic neurons. Morph metric analysis
has shown a significant reduction in the size of the growth
cones after ICRF-193 treatment compared with vehicle
group (Figure 6E and 6F). To determine whether targeting
administration of the inhibitor ICRF-193 can induce dopa-
minergic neuron injury in SN, we stereotaxically injected
ICRF-193 into the MFB of C57BL/6 mice. Studies on cyto-
toxic activity of ICRF-193 in neurons showed that there
was not any significant cytotoxic activity of ICRF-193 at or
below 100 μM [26]. We found that an injection of 2 μl, 50
μM ICRF-193 into the MFB resulted in a significant loss
of nigral TH
+ cells and a reduction of optical density of
striatal TH
+ fibers staining, suggesting that TOP IIb is
necessary for the maintenance of dopaminergic axons in
the VM (Figure 7A-D).
TOP IIb inhibition in vivo affects functional maintenance
of nigro-striatum pathway
In order to study the influence on nigro-striatum path-
way maintenance of ICRF-193 injection into the MFB,
Fluorogold was used as a retrograde tracer. Nigral neu-
rons were labeled by stereotaxic injections of Fluorogold
Table 1 Potential NURR1-interacting sequence motifs
residing in the 5’ upstream flanking region of the Top IIb
promoter
Location Sequence Orientation
From -174 to -167 TGACgTTT R
From -720 to -713 AAAGGTCt F
From -1570 to -1563 cAAGGTCA F
From -1752 to -1745 TGACtTTT R
From -2369 to -2362 AAAtGTCA F
From -3197 to -3190 cAAGGTCA F
From -4401 to -4394 TtACCTTT R
From -4444 to -4437 TGACCTTa R
From -4508 to -4501 aGACCTTT R
From -6190 to -6183 AAAGGTCA F
From -7586 to -7579 AAAtGTCA F
From -9890 to -9883 TGACCTTg R
The 5’ flanking sequences were searched for the presence of NURR1-binding
sequence motifs. Thirteen sequence motifs were identified to have no more
than one base deviation from the consensus NBRE within the 10 kb upstream
region. The deviated base is shown in lower case. The orientation (R: reverse,
F: forward) and location relative to the transcription start site of each motif
are shown.
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Page 6 of 18Figure 3 NURR1 activates the Top IIb promoter through NURR1 binding response elements. A. NURR1 transactivates the Top IIb promoter
in a dose-dependent manner in SH-SY5Y cells. The effect plasmid pCI-Nurr1 was co-transfected with the reporter plasmid pGL3-Top IIb pro into
SH-SY5Y cells. The luciferase activity in the presence of empty vector (pCI) was set to 1. B. Structural requirement for activation of the Top IIb
promoter. SH-SY5Y cells were transiently transfected with Nurr1 mutation construct, which contains a DNA binding deficient mutant (Nurr1
R334A).
Data is shown as fold induction relative to cells transfected with empty vector. C. Point mutations that disrupt the two putative NBREs clearly
reduced the ability of NURR1 to activate the promoter. Data is shown as percentage of the luciferase activity relative to cells transfected with the
original promoter construct. D. Responsiveness to NURR1 is increased when either NBRE1 or NBRE2 site is converted to a consensus NBRE motif.
Data is shown as fold induction relative to cells transfected with the original promoter construct. E. Down-regulation of the basal activity of the
Top IIb promoter by dnNURR1. SH-SY5Y cells were transiently transfected with the promoter construct together with increasing amounts of
dnNURR1 expression plasmids. Data is shown as percentage of the basal activity of the promoter constructs. For the experiments above, the
means of relative luciferase activity (induction fold) ± SEM are presented as the average values from three independent experiments. Samples
are triplicate. *p < 0.05 and **p < 0.01 vs. control. F. ChIP analysis of N2a cells shows recruitment of NURR1 to the endogenous Top IIb promoter.
RT-PCR was performed with primers directed towards NBRE1, NBRE2 or a control region located 3700 base pairs downstream of Top IIb
transcriptional start site. Only the fragment contains NBRE2 was precipitated by NURR1 antibody.
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number of Fluorogold labeled dopaminergic neurons
after ICRF-193 injection was markedly decreased, which
means the nigro-striatum pathway was injured by ICRF-
193 administration and dopaminergic neurons in SN
could not extent their neurites to the striatum (Figure
7E and 7F).
We also measured the catecholamine levels in the
striatum tissue and found that ICRF-193 injection
reduced the levels of DA and its metabolite DOPAC by
43.79% and 58.87% respectively, while 5-HIAA level was
not significantly affected (Figure 7G).
Top IIb deficiency influences the MDNs development and
survival in Top IIb knock-out mice
Expression of TH was dramatically down-regulated in
the VM at E18.5 in the Top IIb null mice (Figure 8).
We found that the TH
+ neurons in SNc were totally
lost in the Top IIb null mice and the number of TH
+
neurons was also decreased in VTA. In WT mouse
brains, we observed a bunch of TH
+ axons extended
from MDNs rostrally along the MFB, while in Top IIb
null mice, we did not detect any fibers generated from
the residual TH
+ neurons in this area. These findings
suggest that TOP IIb is essential for the development
and survival of dopaminergic neurons in the VM and
also plays significant roles in the process of axon
genesis.
Over-expression of TOP IIb rescues Nurr1 deficiency-
induced neurite impairments in SH-SY5Y cells
The pRFP-C1 and pRFP-C1-Top IIb plasmids were trans-
fected to the Nurr1 knock-down stable cell line sepa-
rately. 3 days after transfection, nucleoprotein samples
were collected for Western blot assay. pRFP-C1-Top IIb
plasmids increased TOP IIb protein level significantly
compared with the empty vectors (Figure 9B). Cells
transfected with the plasmids could be identified on an
inverted fluorescence microscope (Olympus IX81, Japan).
Morphological changes were observed 3 days after trans-
fection. Cells transfected with pRFP-C1 plasmids showed
the same morphology as Nurr1-deficiency cells, bearing
occasionally very short neurites. pRFP-C1-Top IIb plas-
mids express a RFP-fused TOP IIb protein, located in the
nucleus and inducing neurite extension(Figure 9A).
Neurite outgrowth in the pRFP-C1 and pRFP-C1-Top IIb
plasmids transfected Nurr1-deficiency cell line accounts
for a significant difference (Figure 9C).
Discussion
NURR1 is known to activate transcription and bind DNA
as monomer on NBRE that consists of an octanucleotide
AAAGGTCA, containing the canonical nuclear receptor
hexanucleotide binding motif preceded by two adenines
[31,35,36]. According to site-directed mutagenesis and
luciferase analysis, we found that both of the NBRE-like
sequences located in the 1600 bp Top IIb promoter
Figure 4 NURR1 regulates TOP IIb expression in vivo. Both of the proteins located in the nucleus. In newborn WT mice, immunofluorescent
analysis showed the co-expression of these two genes in VM area as arrows show (a-c). The expression of TOP IIb in the VM is reduced and
limited to medial area in coronal brain sections of Nurr1 deficient mice (d-f). Arrowheads showed the ventral terminal of the third ventricle (3V).
Scale bar = 100 μm.
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although both of them have a one-base deviation from the
consensus NBRE. However, NBRE2 is more sensitive to
the transactivation of NURR1. One possible explanation is
that NBRE2 is located closer to the transcription start site,
making it more accessible to other co-activators. As the
reporter gene assays totally depend on promoter context
with no consideration of the micro-environment of the
gene, ChIP assay is performed to determine whether
NURR1 is directly recruited to the relevant DNA binding
sites in the natural chromatin in living cells. Our data
demonstrate that NURR1 is recruited to the NBRE2 in the
Top IIb promoter, but not to NBRE1 and the control
region located 3700 bp downstream of Top IIb transcrip-
tional start site. It is possible that NURR1 binds weakly to
the NBRE1 in vivo, and the interaction is undetectable. It
is also possible that NURR1 could not bind NBRE1 in vivo
for the constraints, DNA accessibility, or availability of co-
factors in the cell, which strongly dictate where a tran-
scription factor will actually bind. It seems that NBRE2 is
the more critical site both for binding in intact chromatin
in vivo or transcriptional activation in vitro.
SN dopaminergic neurons selectively project to dorso-
lateral striatum in an orderly medial-to-lateral arrange-
ment, forming the nigro-striatal pathway [37]. Loss of
dopaminergic neurons in the SN is one of the main
pathological features of PD, which may result from the
deficiency of the nigro-striatal pathway. Although the
pathway has been identified for more than three decades,
the underlying molecular mechanism is not well known.
Previous studies suggest that the nigro-striatal circuit is
formed via the regulation by many elements such as spa-
tially and temporally distributed guidance cues, neuro-
trophic factors, morphogens, transcription factors and
other known and unknown molecules.
TOP IIb takes significant role in axon genesis [24],
however the precise molecular mechanism is unclear. Ju
et al. found evidence that TOP IIb activates transcription
by generating a break in double-stranded DNA within a
nucleosome [38]. This enzyme, which is associated with a
Figure 5 Co-expression of TH and TOP IIb in mouse VM. a-c represent an overview of SN and VTA regions. TOP IIb was found expressed in the
nucleus of TH
+ neurons in both VTA region (arrows, d-f) and SN region (arrows, g-i) of P1 mice. Red: TH and green: TOP IIb. Scale bar = 50 μm.
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Page 9 of 18Figure 6 Top IIb deficiency inhibits neurite outgrowth and growth cone formation of primary cultured MDNs. A. ICRF-193 inhibits
neurite outgrowth of MDNs. VM neurons isolated and cultured on PDL-coated cover slips. After 2 hours, ICRF-193 was added to a final
concentration of 20 μMo r4 0μM and the incubation was continued for another 5 days. Neurons were fixed and stained with anti-TH or anti-
MAP2 antibodies. Scale bar = 50 μm. B. Statistic analysis of neurite lengths. Neurite outgrowth of TH
+ neurons in the presence and absence of
ICRF-193 showed significant difference, while neurite lengths of the total neurons (MAP2
+) showed no significant difference. C. and D.N o
significant cell number change was found of the total neuron numbers (MAP2
+) or dopaminergic neuron numbers (TH
+) after the ICRF-193
treatment by cell counting. E. Growth cone formation was abnormal in the presence of ICRF-193. VM neurons isolated and treated with 20 μM,
40 μM ICRF-193 or vehicle for 24 hours. Cells were fixed and stained with Alexa Fluor 488-conjugated phalloidin (for F-ACTIN) and anti-TH
antibody. Red: TH, green: F-ACTIN and blue: DAPi. Scale bar = 10 μm. F. Statistic analysis of the growth cone size. Area measurement of growth
cones was performed by tracing the perimeter of the growth cones using Image J software (NIH, USA). G. Neurite outgrowth of MDNs was
blocked by Top IIb siRNA plasmids. Primary cultured MDNs were transfected with pSUPER-random or pSUPER-Top IIb siRNA plasmids before
seeding using AMAXA nucleofector instrument and cultured for 5 days. Neurons were fixed and stained with anti-TH and anti-GFP antibodies.
Red: TH and green: GFP. Scale bar = 50 μm. H. Measurement of the neurite lengths of the transfected dopaminergic neurons showed pSUPER-
Top IIb siRNA plasmids significantly inhibited the neurite outgrowth. The average neurite length and growth cone size were determined from
more than 100 cells. Bars represent the mean ± SEM resulted from 3 independent experiments. **p < 0.01 vs. control.
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drive gene expression [38]. Large-scale microarray analy-
sis has revealed that a subset of neuronal genes is down-
regulated in the brains of Top IIb knock-out embryos.
The expression of genes encoding proteins involved in
neuron migration (e.g., Reln, Dab1, Sst and Robo1), cell
adhesion (e.g., Catna2, Cdh4, Cdh8, Nell2 and Alcam),
voltage-gated calcium channel activity (e.g., Cacna2d1
Figure 7 ICRF-193-mediated TOP IIb inhibition in SN results in loss of nigro-striatal projection. A. Photomicrographs of TH-
immunostained sections of SN of the 2-month-old mice treated with 2 μl5 0μM ICRF-193 (a) and vehicle (b) for 2 weeks. C. Photomicrographs
of TH-immunostained sections of striatum of the 2-month-old mice treated with 2 μl ICRF-193 (a) and vehicle (b) for 2 weeks. B. and D.
Quantitative analysis of the number of TH
+ neurons or optical density of striatal TH
+ fibers in the right SN (B) or striatum (D). E. Effect of ICRF-
193 on nigra-striatum pathway maintenance. SN neurons were labeled by stereotaxic injections of Fluorogold two weeks after ICRF-193 or
vehicle treatment. F. Statistic analysis showed that the number of Fluorogold labeled dopaminergic neurons was robustly decreased after ICRF-
193 injection. G. Effect of ICRF-193 on neural transmitter release of dopaminergic neurons. Striatal DA, its metabolite DOPAC and 5-HIAA
concentrations were tested by HPLC. The results above are expressed as means ± SEM of 4 mice in each group. *p < 0.05 and **p < 0.01 vs.
vehicle control. Arrows show the injection side. Scale bar = 100 μm.
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+ neurons and fibers in the VM of Top IIb null mice. TH-immunostaining was performed in sagittal sections of E18.5 Top
IIb
+/+ and Top IIb
-/- mice brains. The location of TH
+ neurons areas were indicated by horizontal arrows (SNc) and arrowheads (VTA). Vertical
arrowheads indicated the location of the TH
+ fibers extended from SNc and VTA (a and b). c and d showed in higher magnification that the TH
+ neurons in SNc was loss in Top IIb
-/- mice, while the number also decreased in VTA. Bar = 100 μm.
Figure 9 Over-expression of TOP IIb rescues Nurr1 deficiency-induced neurite impairments in SH-SY5Y cells. A. The pRFP-C1 and pRFP-
C1-Top IIb plasmids were transfected to the Nurr1 knock-down stable cell line separately. Morphological changes were observed 3 days after
transfection. Cells transfected with pRFP-C1 plasmids showed the same morphology as Nurr1 deficient cells, bearing occasionally very short
neurites. pRFP-C1-Top IIb plasmids express a RFP-fused TOP IIb protein which located in the nucleus and induced neurites extension. B. After
transfection for 3 days, pRFP-C1-Top IIb plasmids increased TOP IIb protein expression level of the cells significantly compared to the empty
vectors. C. The average neurite length (total neurite length/cell number) was determined from more than 100 cells. Bars represent the mean ±
SEM (n = 3 independent experiments). Neurite outgrowth in the pRFP-C1 and pRFP-C1-Top IIb plasmids transfected Nurr1-deficiency cell line
showed significant difference. **P <0.01 vs. empty vector. Bar = 20 μm.
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cytoskeleton formation (e.g., neurofilament)a r ed o w n -
regulated in the mutant [25]. Using functional immuno-
precipitation strategy to identify genomic sites directly
targeted by TOP IIb, several genes were discovered
encoding membrane proteins with ion channel, transpor-
ter, or receptor activities [38]. Significant proportions of
them encode long transcripts and are juxtaposed to a
long AT-rich intergenic region [39]. These studies sup-
port the notion that TOP IIb is required for neurite out-
growth during neuronal differentiation, possibly at the
level of gene expression.
A recent report also reveals that TOP IIb is associated
with genomic instability in the cerebella region of aging
brain [40]. TOP IIb is treated as an additional biomarker
in DNA repair and aging using cultured cerebella granule
neurons as an in vitro aging model [41]. It has been sug-
gested that neurons may be more sensitive to repair defi-
ciency than other cell types [42]. Thus, the observed
neural defects in Top IIb mutant embryos might be
related to the plausible involvement of TOP IIb in DNA
repair. Ju et al. identified a connection between initiations
of transcription and sensing and repairing of DNA dou-
ble strand breaks, and found a new chromatin specific
function for TOP IIb [38]. These studies undoubtedly sti-
mulate new conceptual views about the interplay
between regulated gene transcription and the DNA
damage response.
It has been shown that TOP IIb is highly expressed in
differentiating cerebella neurons. It is the catalytically
competent entity operating directly on chromatin DNA in
vivo [43]. In our studies, we first report the expression
profile of TOP IIb in VM dopaminergic neurons. ICRF-
193 is a very significant TOP II poison and causes dose-
dependent cross-linking of human TOP IIb to DNA and
stimulates TOP IIb-mediated DNA cleavage at specific
sites on
32P-end-labeled DNA [44]. It functions through
both TOP IIb-specific down-regulation and inhibition of
TOP IIb catalytic activity by activating a 26S proteasome
pathway [33,45]. TOP IIa-mediated DNA cleavage was sti-
mulated to a lesser extent by ICRF-193 [44]. In the present
study, we administrated ICRF-193 in a primary culture of
VM neurons as well as nigra-stratum pathway in vivo.O u r
in vitro studies indicate that TOP IIb is required for neur-
ite outgrowth and growth cone formation. However the in
vivo studies illustrate a significant loss of dopaminergic
neurons in SN, striatal dopamine content and injury of the
nigra-striatum pathway after stereotaxically injection of
ICRF-193 into the MFB of C57BL/6 mice. After TOP IIb
inhibition, the dopaminergic neurons could not maintain
the extension of their axons to the striatum, resulting in
fail to uptake and retro-transport the neurotrophic factors
to the nigral neurons. Consequently, the nigral dopami-
nergic neurons degenerate and die. In order to rule out
the side-effect of ICRF-193, we applied RNAi strategy in
vitro and observed a similar result as shown in ICRF-193
experiments, confirming that TOP IIb is required for axon
genesis and extension due to its own catalytic function in
dopaminergic neurons.
Our results may provide important insights into the
mechanisms whereby NURR1 is functioning during
mesencephalon development and cell differentiation.
Through a combination of Nurr1 deficient mice and geno-
mic expression profiling technology, we identified genes,
which would possibly mediate the phenotype previously
observed in Nurr1 deficient mice. Recent studies suggest
that many axon-guidance pathway genes, such like DCC,
EPHB1, NTNG1, SEMA5A and SLIT3 were differentially
expressed in PD [46,47]. The understanding of the pro-
cesses of neurite outgrowth, axonal guidance and synapto-
genesis is fundamental for developing treatments of PD.
The results from our study provide the first evidence and
novel molecular mechanisms by which NURR1 interacts
with TOP IIb to regulate MDNs development, differentia-
tion and functional maintenance. These findings may
open up a new avenue to explore the possible association
of Nurr1-Top IIb in MDNs dysfunction related disease,
including PD.
Conclusion
NURR1 can regulate TOP IIb expression both in vivo and
in vitro. Top IIb is a direct downstream target of Nurr1.
NURR1 can be recruited to the functional NURR1 binding
sites which were identified in the Top IIb promoter. The
alterations in TOP IIb are associated with axon genesis in
dopaminergic neurons. Knock-down Top IIb affects the
neurite outgrowth, growth cone development and nigro-
striatum pathway maintenance. Top IIb deficiency ser-
iously influences the MDNs development and survival in
developing stages as the MDNs are severely lost in E18.5
Top IIb knock-out mice.
Methods
Experimental animals
Nurr1 deficient mice were generated by Dr. Conneely’s
laboratory as previously described [1]. Paired Nurr1
knock-out heterozygous (Nurr1
+/-) mice with the same




-/- offspring used in the pre-
sent study. The genotype of the mice was analyzed with
PCR using mouse tail genomic DNA. Three primers were
used: a 5’ primer (GGCACTCCTGTGTCTAGCTGCC)
located in the end of the neo
τ gene in exon 3, and two 3’
primers, one (CTGCCTTGGGAAAAGCGCCTCC) in
the neo
τ gene to generate a 200-bp band representing the
mutated allele and the other (CAGCCCTCACAAGTGC-
GAACAC) in a 3’ portion of exon 3 to generate a 300-bp
WT band [1]. The Top IIb
-/- mice were kindly provided
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UMDNJ-Robert Wood Johnson Medical School [25].
Pups with a Top IIb deletion were identified by the pre-
sence of a 450-bp product in a PCR by using the primer
pair PR3 (5’-ATATGGTACAGCAACAAAGCATTTGA-
CATA-3’)a n dP R 7( 5 ’-GAATTGTT TGCTGTGGATG-
CATGTA-3’) [28]. WT strains C57BL/6 and ICR were
purchased from Experimental Animal Center of Shang-
hai, China. Mice were mated for 2 hours and subse-
quently examined for a vaginal plug. Twenty-four hours
later, they were designated as E1. Animal care and
experimental procedures were performed in accordance
with the National Institute of Health Guide for the Care
and Use of Laboratory Animals (NIH Publications No.
80-23) and the Laboratory Animal Care Guidelines
approved by Shanghai Institutes for Biological Sciences
of Chinese Academy of Sciences.
RNA extraction
Mesencephalic tissues were dissected from newborn mice
according to method described before [48]. Tissues in
each genotyping group were pooled separately and frozen
immediately on dry ice. RNA was isolated from tissue
samples using RNeasy mini-columns and treated on the
column with DNaseI according to manufacturer’s instruc-
tions (Qiagen Inc., USA). The quality of total RNA was
checked with spectrometer and gel electrophoresis.
Microarray experiment
The expression of ≈ 36,700 transcripts containing ≈ 12,423
genes and ESTs represented on the Affymetrix Mouse
Genome 430 gene chips was quantified in pooled samples
from Nurr1-null homozygous and wide type mice. For
each array, the RNA used was from samples pooled from
5 animals in each group. Triplicate hybridizations were
performed for each sample. cDNA synthesis, cRNA label-
ing, hybridization and scanning were accomplished
according to manufacturer’s instructions (Affymetrix). The
raw data were initially analyzed using Microarray Suite
version 5.0 (Affymetrix), which calculates normalized
expression levels and generates ratios of experimental/
control signals with P values based on the 8-20 different
probe pairs that represent each gene on the array. Then,
data sets from comparison files were imported into excel
(Microsoft) for further comparative analysis. Analysis
parameters for gene filtering used by the software were set
to values corresponding to high stringency (difference
threshold = 100, ratio threshold = 2.0). Affymetrix NetAffx
database (http://www.NetAffx.com) was used to annotate
probe sets.
Real-time PCR analysis
Oligonucleotide primers, probes, and reagents (TaqMan
universal PCR Master Mix) were purchased from
Applied Biosystems. Five genes were selected and veri-
fied by TaqMan real-time PCR. The genes and TaqMan
probe ID were shown in Additional file 1, Table S1.
The experimental conditions were followed in accor-
dance with the manufacturer’s protocol. Amplification
and detection of specific products were performed in
the ABI Prism 7900 sequence detection system (Applied
Biosystems), and a standard curve and Ct value were
obtained.
Real-time PCR for samples from N2a cells was con-
ducted using SYBR Green Real-time PCR Master Mix
(Toyobo, Japan) and the primers are listed as follows:
Nurr1;5 ’-CGGCTCTATGGAGATCATCA-3’ and 5’-
CAATGGAATCAATCCATTCC-3’, Top IIb;5 ’-GCCCA
ACTATGATGCTAGAG-3’ and 5’- ACAGCATACTGG
TTCTGACC-3’, Gapdh;5 ’-TGACCACAGTCCATGC-
CATC-3’ and 5’-GACGGACACATTGGGGGTAG-3’.
Samples were triplicate and each sample was performed in
3w e l l s .
Stable transfection and selection of Nurr1 knock-down
SH-SY5Y cell clones
SH-SY5Y cells were bought from Cell Resources Center of
Shanghai Institutes for Biological Sciences, Chinese Acad-
emy of Sciences. The cells were grown on poly-D-lysine
(Sigma, USA) pre-coated dishes in Dulbecco’s modified
Eagle’s medium, (DMEM, GIBCO-Invitrogen, USA) sup-
plemented with 10% fetal bovine serum (heat-inactivated,
GIBCO-Invitrogen). The siRNA target sequences are as
follows: Nurr1 (5’-CCAGAGTTTGTCAAGTTTA-3’) and
random (5’-GTGGAGCCGAGTTTCTAAATTCCG-3’).
SH-SY5Y cells were transfected with plasmids: pSUPER-
Nurr1 siRNA or pSUPER-random using lipofectamine
2000 (Invitrogen, USA). Cells that have stably incorpo-
rated the GFP plasmid into their genomic DNA were
selected with 600 μg/ml neomycin (Duchefa, Holland).
The clones were expanded and picked on an inverted
fluorescence microscope (Olympus IX81, Japan). Total
proteins from each clone were collected. Clones with
decreased expression of NURR1 were identified by Wes-
tern blot analysis using anti-NURR1 antibody (Santa Cruz,
USA).
Neurite length analysis
The total neurite length per neuron was determined and
calculated as the sum of the lengths of all neurites of a sin-
g l en e u r o n .T h ea v e r a g et o t a l neurite length per experi-
mental condition was determined from a sample of at
least 100 neurons from random fields.
N2a cell culture and transient transfection
N2a cells were bought from Cell Resources Center of
Shanghai Institutes for Biological Sciences, Chinese
Academy of Sciences. The cells were grown in Dulbecco’s
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USA) supplemented with 10% fetal bovine serum (heat-
inactivated, GIBCO-Invitrogen). Cells were maintained at
37°C in an incubator containing 5% CO2.T h es t e a l t h




3’) (Cat. No: 152999), and a random sequence used as a
negative control (Cat.No:12935300). N2a cells were
transfected with stealth siRNA using lipofectamine 2000
(Invitrogen, USA).
Western blot analysis
Nucleoprotein was isolated from N2a cells (3 days after
transfection) using the Proteo JET™ cytoplasmic and
nuclear protein extraction kit (Thermo Fisher Scientific,
USA). 50 μg of protein from each sample were loaded
onto 10% SDS-PAGE and transferred to polyvinylidene
difluoride (PVDF). After being blocked for 1 hour in 5%
non-fat milk, the PVDF membrane was incubated with
primary antibodies overnight at 4°C. The primary antibo-
dies are listed as follows: anti-NURR1 (Santa Cruz, USA),
anti-TOP IIb (Santa Cruz, USA), anti-LAMIN B (Santa
Cruz, USA) and anti-b-ACTIN (Sigma, USA). After wash-
ing with TBST, samples were incubated with peroxidase-
conjugated secondary antibody. The immunoreaction was
developed using Super Signal West Dura Extended Dura-
tion Substrate (Pierce Biotechnology, USA), and the signal
was quantified by measuring optical density of the bands.
Plasmids construction
The Top IIb promoter fragment was amplified from
mouse genomic DNA using the primers:-1380/+237:5’-
AAGGCCCGATGATGGACTTGGGAAAGCT-3’ and 5’-
ATTGGGATCGCG GATGAGGGACGAGGTT-3’.B a s e
substitutions in the NBRE-like motifs on Top IIb promoter
were introduced into the promoter sequence using the
Muta-direct kit (Beijing SBS Genetech Co., Ltd) according
to the manufacturer’s instructions. The following oligo
nucleotides were used in the mutagenesis procedure:
NBRE1 mutant primer; 5’-GCATTGTTGGGAGGAAATT
TCTGTAGCCAGAAAAGG-3’, NBRE2 mutant primer;
5’-GTTGCTACCCGCAATGAAATTTTCCCCTCGGG
TCCCG-3’ (underlined base pairs indicate the mutated
bases). NBRE(C)1 primer had a consensus NBRE motif at
NBRE1 position by changing T at the last position of
N B R E 1t oA :5 ’- GCATTGTTGGGAGGAAAGGTCAG-
TAGCCAGAAAAGG-3’.N B R E ( C ) 2p r i m e rh a dac o n s e n -
sus NBRE motif at NBRE2 position by changing G at the
fifth position of NBRE2 to C: 5’-GTTGCTACCCGCAAT-
GACCTTTTCCCCTCGGGTCCCG-3’. All promoter con-
structs were cloned into the pGL3-Basic plasmid
(Promega, USA) containing the firefly luciferase gene.
Mouse NURR1 over-expression vector pCI-Nurr1 was
generously donated by Sotirios Tetradis (University of
California, Los Angeles). pCI-Nurr1
R334A has an alanine in
position R334 [17]. Dominant negative Nurr1 contains a
truncated sequence of Nurr1 (amino acids 94-365), fol-
lowed by the sequence of the repressor domain from the
Drosophila Engrailed protein [17]. To generate mouse
TOP IIb over-expression vector, total RNA from mouse
midbrain at postnatal day 1 was isolated using TRIzol
(Invitrogen, USA) and cDNA synthesis was carried out
with reverse transcriptase (Toyobo, Japan). The full open
reading frame of mouse Top IIb was amplified by PCR
with KOD-plus polymerase (Toyobo, Japan) and the fol-
lowing primers: forward 5’- CTCGAGCTATGGCCAAG
TCCAGCCTC -3’;r e v e r s e5 ’- GTCGACTTAATTAAA-
CATTGCA-3’. The fragment was inserted into pRFP-C1
vector from the sites: XhoI and SalI. pRFP-C1 vector is
derived from pEGFP-C1 vector and has a red fluorescent
protein coding sequence instead of EGFP. The TOP IIb
protein expressed by the plasmid was fused with RFP.
Luciferase assay
In preliminary experiments, SH-SY5Y cells were used to
set the optimal cell density and plasmid concentration for
the luciferase assay experiment. The reporter assays were
performed in 24-well plates using lipofectamine 2000
reagent (Invitrogen, USA). For the promoter analysis, the
plasmids pGL3-Top IIb NBRE1mut, pGL3-Top IIb
NBRE2mut, pGL3-Top IIb NBRE(C)1 and pGL3-Top IIb
NBRE(C)2 were transfected with NURR1 over-expression
plasmid pCI-Nurr1. The renilla luciferase vector pRL-
SV40 was used as an internal control. Each well was trans-
fected with 400 ng Top IIb promoter plasmid, 400 ng pCI-
Nurr1 and 8 ng pRL-SV40. Cells were harvested 48 hours
after transfection and lysed in Passive Lysis Buffer (Pro-
mega, USA). Firefly and renilla luciferase luminescence
were measured using the Dual-Luciferase
® Reporter Assay
System (Promega, USA) according to the manufacturer’s
instructions. Firefly luminescence was normalized against
renilla luminescence for each well, and relative values (fold
induction) were calculated by setting the normalized value




6 SH-SY5Y cells grown in 10 cm cell dishes
were treated with 1% formaldehyde solution for 10 min
at 37°C to cross-link histones, and resuspended in lysis
buffer containing 1% SDS, 10 mM EDTA, 50 mM Tris-
HCl, pH 8.1, and then were sonicated to shear DNA.
DNA was recovered, and histone-DNA cross-links were
reversed in an aliquot, which subsequently was used in
PCR reactions to evaluate the amount of DNA present in
various groups. The remaining DNA-histone complexes
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1 μg of NURR1 specific antibody (E-20, sc-990x, Santa
Cruz, USA) or rabbit IgG as a control antibody (Cell Sig-
naling Technology, USA), and a salmon sperm DNA/
Protein A-agarose slurry (GE Healthcare, Sweden). His-
tone-DNA cross-links were reversed, and DNA was
recovered and used in PCR reactions utilizing primers
that bracket the proximal NBRE-like sites in the Top IIb
promoter. The sequences of the primers that encompass
the proximal NBRE-like element were 5’-CTGGGTA
AAGTTCTTCGG-3’ and 5’-GTGCCACCAGTTAGG
GA-3’;5 ’-CCCGGAATGACTCTTGACA-3’ and 5’-
CGGCATAACACGGCACA-3’in the proximal mouse
Top IIb promoter; and against a control region 3.7 kb
downstream of the transcriptional start site 5’-GAC
AATGCCCTCGCCTTAC-3’ and 5’-GCTTTGGATT
TGCCTGAA-3’.
Primary ventral MDNs cultures
Primary ventral mesencephalic (VM) neuron-enriched cul-
tures isolated from E13.5 mouse fetuses were cultured on
PDL-coated coverslips (Wanner Instruments, USA). The
cells were allowed to grow in a serum-free medium with
B27 (GIBCO-Invitrogen, USA). After 2 hours, ICRF-193
was added to a final concentration of 20 μMo r4 0μM
separately. The incubation was continued for another 24
hours for growth corn formation analysis and 5 days for
neurite length measurement. Cells were fixed and stained
with anti-TH antibody and Alexa Fluor 488-conjugated
phalloidin for F-ACTIN staining. The neurite length and
growth cone area of the immuno-reactive neurons were
measured and analyzed. For electroporation, the primary
VM neurons were homogenously resuspended with the
transfection buffer to a final concentration of 4-5 × 10
6
/100 μl and mixed with 2 μg plasmid DNA of either pSU-
PER- Top IIb siRNA or pSUPER-random. The siRNA tar-
get sequences are as follows: Top IIb (5’-CAACTATGA
TGCTAGAGAA-3’) and random (5’-GTGGAGCC-
GAGTTTCTAAATTCCG -3’). Electroporation was per-
formed with an AMAXA Nucleofector instrument as per
the manufacturer’s protocol. The transfected neurons
were then seeded to 24-well plates containing poly-D-
lysine coated coverslips. After 5 days, the cells were fixed
and stained with anti-TH and anti-GFP antibodies.
Immunohistochemical and immnunofluorescent staining
VM cells or tissue sections were fixed in 4% paraformalde-
hyde at room temperature for 30 min. For immunohisto-
chemical staining, cells or tissue sections were treated with
0.3% H2O2 and then blocked with a pretreatment solution
(PBS containing 4% horse serum and 0.3%Triton-X-100)
at room temperature for 30 min, followed by incubation
overnight at 4°C with TH antibody (1:500, Millipore,
USA). After incubation with biotinylated secondary
antibody (1:200, Vector, Burlingame, CA) at room tem-
perature for 2 hours, the Vector ABC kit (Vector, USA)
and diaminobenzydine (DAB)-H2O2 were used to visualize
perspective cells. For immnunofluorescent staining, the
cells were blocked in the pretreatment solution at room
temperature for 30 min, followed by incubation with TH
antibody (1:500, Millipore, USA), NURR1 antibody (1:100,
Santa Cruz, USA) or TOP IIb antibody (1:50, Santa Cruz,
USA) overnight at 4°C, then with FITC-conjugated (1:400,
Vector, USA) or TRITC-conjugated IgG (1:800, Vector,
USA) at room temperature for 2 hours. Finally, the visual
area was covered with a coverslip mounted with anti-fade
Aqua Poly/Mount (Polysciences, USA), and then visua-
lized and photographed using an inverted fluorescence
microscope (Olympus IX81, Japan) equipped with a DP70
CCD digital camera (Olympus, Japan).
Stereotaxic injection
For administration of TOP II inhibitor ICRF-193 in vivo,
male C57BL/6 mice weighting 22-26 g were anesthetized
with chloral hydrate and mounted on a Benchmarker
stereotaxic apparatus (myNeurolab, St. Louis, MO, USA) in
a sterilized chamber. Each animal received an injection of
either ICRF-193 of different concentrations (Biomol, USA)
in 2 μl vehicle (0.1% dimethyl sulfoxide, DMSO) or vehicle
alone as a control into the right medial forebrain bundle
( M F B )a taf l o wr a t eo f1μl/min (AP -1.3 mm, ML ±
1.1 mm DV -5.25 mm from Bregma) [49].
In order to study the influence on nigra-striatum path-
way formation of ICRF-193 injection, Fluorogold (Fluoro-
chrome, USA) was used as a retrograde tracer. Two weeks
after ICRF-193 or vehicle injection, each animal received
an injection of 0.2 μl Fluorogold (AP 0.8 mm, ML ± 2 mm
DV -3 mm from Bregma) [49].
Biochemical analysis of catecholamines
The whole right striatum was dissected and homogenized
(10%wt/vol) by sonication in ice-cold 0.2 M perchloric
acid with 3, 4-dihydroxybenzylamine (DHBA) as internal
standard. Homogenate was centrifuged at 20,000 g for 15
min at 4°C and the supernatant was collected. The levels
of DA, 3, 4-dihydroxyphenylacetic acid (DOPAC) and 5-
hydroxyindolacetic acid (5-HIAA) were determined by
high-pressure liquid chromatography (HPLC; EPC-300,
Eicom, Japan) equipped with a column of 5 μm spherical
C18 particles and detected with an electrochemical detec-
tor. The mobile phase (previously filtered and degassed)
consisted of 0.042 M citric acid monohydrate, 0.038 M
sodium acetate trihydrate, 0.94 mM sodium octane sulfo-
nate and 0.013 mM EDTA-2Na (pH 3.8).
Statistics
Statistical significance between groups was assessed by
t-tests using GraphPad Prism (GraphPad Software, Inc.,
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significant.
Additional material
Additional file 1: Comparison of genes expression in Nurr1
-/- mice
vs. WT mice. Microarray analysis was employed and several genes were
identified with altered expression in the mesencephalon of WT and
Nurr1
-/- mice at P1.
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dopaminergic neurons; MFB: medial forebrain bundle; N2a: Neuro-2a; NBRE:
NGFI-B response element; PD: Parkinson’s disease; PCR: polymerase chain
reaction; SNc: substantial nigra pars compacta; TOP IIβ: Topoisomerase IIβ;
TH: tyrosine hydroxylase; VM: ventral mesencephalic; VTA: ventral tegmental
area; WT: wide type.
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